EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 288 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $784,000 | -13.7% | 25,250 | +14.2% | 2.30% | +10.5% |
| Q1 2022 | $908,000 | +1.5% | 22,111 | +7.4% | 2.08% | +45.6% |
| Q4 2021 | $895,000 | -34.9% | 20,591 | -25.0% | 1.43% | -14.0% |
| Q3 2021 | $1,375,000 | +15.4% | 27,460 | +45.2% | 1.67% | +19.3% |
| Q2 2021 | $1,191,000 | -38.8% | 18,915 | -9.7% | 1.40% | -34.9% |
| Q1 2021 | $1,947,000 | +437.8% | 20,957 | +357.9% | 2.14% | +310.7% |
| Q2 2020 | $362,000 | +37.1% | 4,577 | +0.2% | 0.52% | +22.2% |
| Q1 2020 | $264,000 | 0.0% | 4,570 | -6.7% | 0.43% | +81.7% |
| Q4 2019 | $264,000 | 0.0% | 4,897 | -3.0% | 0.24% | -18.7% |
| Q3 2019 | $264,000 | -14.6% | 5,050 | +7.5% | 0.29% | +105.0% |
| Q3 2018 | $309,000 | -27.3% | 4,697 | -41.8% | 0.14% | -7.2% |
| Q1 2018 | $425,000 | +30.4% | 8,066 | +15.0% | 0.15% | +36.9% |
| Q4 2017 | $326,000 | +19.4% | 7,016 | +4.1% | 0.11% | +26.1% |
| Q3 2017 | $273,000 | – | 6,741 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 119,994 | $12,399,000 | 6.09% |
| Hillcrest Asset Management LLC | 161,826 | $16,721,000 | 2.96% |
| SNYDER CAPITAL MANAGEMENT L P | 664,662 | $68,680,000 | 2.94% |
| Copper Rock Capital Partners, LLC | 83,374 | $8,615,000 | 2.91% |
| RICE HALL JAMES & ASSOCIATES, LLC | 623,132 | $64,388,000 | 2.60% |
| Tygh Capital Management, Inc. | 130,526 | $13,487,000 | 2.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 428,875 | $44,316,000 | 1.31% |
| BECK CAPITAL MANAGEMENT, LLC | 22,067 | $2,280,000 | 1.29% |
| EARNEST PARTNERS LLC | 1,394,794 | $144,124,000 | 1.24% |
| DC Investments Management, LLC | 10,945 | $1,131,000 | 1.24% |